Three lessons from the Federal Circuit’s recent 101 reversal in XY v Trans Ova Genetics

In this contributed article, Kirkland partner John O’Quinn and associate Hannah Bedard explore key lessons from the Federal Circuit’s recent precedential decision in XY v Trans Ova Genetics.

“Litigants addressing section 101 challenges should focus on articulating what the claimed invention is, how it relates to the prior art, and how the claims compare to others that courts have already held to be eligible, or ineligible, under section 101.”

Read the full article